ArticleNeuropharmacology2018

Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation.

Yatendra Mulpuri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.